Epidemiological and clinical studies report higher incidences of anxiety and increased emotional reactivity in individuals suffering from respiratory allergies. To evaluate if respiratory allergies are capable of promoting anxiety-like behavior in rodents, we used models of allergic rhinitis and behavioral evaluations followed by assessment of mRNA for cytokines in relevant brain regions. Mice and rats were sensitized to ovoalbumin or pollen, respectively, following standard sensitization and challenge protocols. After challenge, the animals were evaluated in the open field, elevated plus-maze and resident-intruder tests. Cytokines and corticotropin-releasing factor expression were assessed in several brain regions by real-time RT-PCR and plasma corticosterone concentrations by radioimmunoassay. Mice and rats sensitized and exposed to allergen showed increased anxiety-like behavior and reduced social interaction without any overt behavioral signs of sickness. T-helper type 2 (T H 2) cytokines were induced in both rats and mice in the olfactory bulbs and prefrontal cortex and remained unchanged in the temporal cortex and hypothalamus. The same results were found for CRF mRNA expression. No differences were observed in corticosterone concentrations 1 h after the last behavioral test. These results show that sensitization and challenge with allergens induce anxiety across rodent species and that these effects were paralleled by an increased expression of T H 2 cytokines and CRF in the prefrontal cortex. These studies provide experimental evidence that sensitized rodents experience neuroimmune-mediated anxiety and reduced social interaction associated with allergic rhinitis.
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Introduction
Allergic rhinitis affects about 20-30% of adults and up to 40% of children (Meltzer, 1997; Sly, 1999 Sly, , 2002 Berger, 2004; Nathan, 2007; Blaiss, 2007) and contributes to the development of allergic asthma (Meltzer et al., 2004; Meltzer, 2005) . A hallmark of allergic disease is the expansion of the type 2 (T H 2) subset of T cells and the generation of IgE antibodies to common allergens. In the sensitized individual following exposure to antigen, there is an early phase hypersensitivity response within 30 min, which may be followed by a late phase response 2-6 h later (Galli et al., 2008) . If there is ongoing exposure to antigen, allergic inflammation can persist for days or longer. The early phase primarily results from mast cell degranulation and release of pre-formed and newly synthesized mediators, like proteases, histamine and leukotrienes which effect vascular permeability, and mucus production. Release of chemokines and recruitment of inflammatory cells contribute to the late phase response which is characterized by an influx of eosinophils, and T H 2 lymphocytes which produce T H 2 cytokines such as IL-4 and IL-13 (Galli et al., 2008) .
Allergic rhinitis is associated with congestion, nasal discharge, palatal itch and sneezing, however, some patients report symptoms of fatigue and changes in mood. The most recognized behavioral complications of allergic rhinitis noted by clinical practitioners are the development of fatigue and sleep disturbances as a consequence of obstruction of the airways (Meltzer, 1997; Schoenwetter et al., 2004; Santos et al., 2006; Woods and Craig, 2006; Sundberg et al., 2007) . However, psychiatric complications including anxiety and altered emotional reactivity are also acknowledged (Addolorato et al., 1999; Marshall et al., 2002; Buske-Kirschbaum et al., 2008; Chida et al., 2008; Blaiss, 2008) . Nonetheless, the extent to which allergic rhinitis may contribute to
